World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
45823
World Ranking
1333
National Ranking
685

Overview

William C. Gruber is affiliated with Pfizer in the United States and has an extensive publication record in the field of medicine, with a focus on epidemiology and infectious diseases. Their research contributions span multiple topics, including respiratory infections, viral research, and public health.

Their recent papers include the following:

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine, 2020, New England Journal of Medicine
  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates, 2020, New England Journal of Medicine
  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults, 2020, Nature
  • Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents, 2021, New England Journal of Medicine
  • Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants, 2023, New England Journal of Medicine

The scientist frequently collaborates with the following coauthors:

  • Kena A. Swanson (43 publications)
  • Alejandra Gurtman (38 publications)
  • David Cooper (37 publications)
  • Kathrin U. Jansen (35 publications)
  • Annaliesa S. Anderson (35 publications)

Their most common publication venues include:

  • Open Forum Infectious Diseases (18 publications)
  • New England Journal of Medicine (13 publications)
  • Vaccine (11 publications)
  • Clinical Infectious Diseases (7 publications)
  • The Journal of Infectious Diseases (6 publications)

Their main fields of study focus on medicine, with subfields in epidemiology, infectious diseases, microbiology, health, and public health, environmental and occupational health.

The primary topics of their work cover a range of subjects such as:

  • Pneumonia and Respiratory Infections
  • Respiratory viral infections research
  • SARS-CoV-2 and COVID-19 Research
  • Viral gastroenteritis research and epidemiology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Bacterial Infections and Vaccines
  • Influenza Virus Research Studies

Best Publications

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.

    Fernando P. Polack;Stephen J. Thomas;Nicholas Kitchin;Judith Absalon

  • Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.

    Edward E. Walsh;Robert W. Frenck;Ann R. Falsey;Ann R. Falsey;Nicholas Kitchin

  • Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults.

    Mark J. Mulligan;Kirsten E. Lyke;Nicholas Kitchin;Judith Absalon

  • Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

    Marc J.M. Bonten;Susanne M. Huijts;Marieke Bolkenbaas;Chris Webber

  • The Efficacy of Live Attenuated, Cold-Adapted, Trivalent, Intranasal Influenzavirus Vaccine in Children

    Robert B. Belshe;Paul M. Mendelman;John Treanor;James King

  • Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.

    Unknown

  • Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.

    Robert W Frenck;Nicola P Klein;Nicholas Kitchin;Alejandra Gurtman

  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.

    Stephen J. Thomas;Edson D. Moreira;Nicholas Kitchin;Judith Absalon

  • Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

    David W. Kimberlin;Chin Yu Lin;Richard F. Jacobs;Dwight A. Powell

  • Efficacy and Safety of a Bivalent RSV Prefusion F Vaccine in Older Adults.

    Unknown

  • Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.

    Emmanuel B. Walter;Kawsar R. Talaat;Charu Sabharwal;Alejandra Gurtman

  • Natural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era

    David W. Kimberlin;Chin-Yu Lin;Richard F. Jacobs;Dwight A. Powell

  • Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine.

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Iksung Cho

  • Correlates of Immune Protection Induced by Live, Attenuated, Cold-Adapted, Trivalent, Intranasal Influenza Virus Vaccine

    Robert B. Belshe;William C. Gruber;Paul M. Mendelman;Harshvardhan B. Mehta

  • Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.

    Richard J. Whitley;Gretchen Cloud;William Gruber;Gregory A. Storch

  • Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

    Douglas M Fleming;Pietro Crovari;Ulrich Wahn;Timo Klemola

  • SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3.

    Ann R Falsey;Robert W Frenck;Edward E Walsh;Nicholas Kitchin

  • Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.

    Bruce D. Forrest;Michael W. Pride;Andrew J. Dunning;Maria Rosario Z. Capeding

  • Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory

    Andrés de Roux;B. Schmöele-Thoma;G. R. Siber;J. G. Hackell

  • Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections

    Shai Ashkenazi;Andre Vertruyen;Javier Arístegui;Susanna Esposito

  • Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants

    Ruth A. Karron;Peter F. Wright;Robert B. Belshe;Bhagvanji Thumar

  • Influenza virus infections in infants.

    W. Glezen;Larry Taber;Arthur Frank;William Gruber

Frequent Co-Authors

Daniel A. Scott
Daniel A. Scott Pfizer (United States)
Kathrin U. Jansen
Kathrin U. Jansen Pfizer (United States)
Robert W. Frenck
Robert W. Frenck Cincinnati Children's Hospital Medical Center
Peter F. Wright
Peter F. Wright Dartmouth College
Emilio A. Emini
Emilio A. Emini Pfizer (United States)
Robert B. Belshe
Robert B. Belshe Saint Louis University
Annaliesa S. Anderson
Annaliesa S. Anderson Pfizer (United States)
David A. Cooper
David A. Cooper University of New South Wales
Marc J. M. Bonten
Marc J. M. Bonten Utrecht University
Ron Dagan
Ron Dagan Ben-Gurion University of the Negev

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees in nursing can open diverse career paths in healthcare and research. Many professionals begin with foundational programs like the easiest ABSN program to get into, designed specifically for those transitioning from non-nursing backgrounds. These accelerated Bachelor of Science in Nursing programs offer a streamlined path to enter the nursing field quickly.

Once established in nursing, continuing education options such as the accelerated FNP programs provide a faster route to earn a Family Nurse Practitioner certification. This can enhance your clinical expertise while allowing you to address immunology-related health issues at a broader patient care level.

Transitioning further, nurses can pursue specialized credentials like the FNP to acute care certification, focusing on acute and emergency care settings. This pathway not only broadens practical skills but also aligns closely with immunological conditions requiring urgent intervention.

Additionally, for those without prior nursing experience, comprehensive online nursing programs for non nurses offer flexible entry points. These programs enable students to build foundational nursing knowledge that complements immunology studies and opens doors to numerous clinical and research roles.

Best Scientists Citing William C. Gruber

Trending Scientists